Nes-Ziona, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…
CHARLOTTE, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that its first quarter 2022…
-- Levels of Ki67+ expression by CD8+T cells and NK cells increased by 17-fold and 10-fold, respectively, in the third…
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S.…
MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and…
Imagene AI team Imagene Founders Jonathan Zalach, Dean Bitan and Shahar Porat, Chief Scientific Officer Dr. Nurit Paz-YaacovImagene's proprietary deep…
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is…
Presentations to feature laterally spreading capsid for the treatment of X-linked retinoschisis and dual vector technology for the treatment of…
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell therapyFindings…
BFYW is Expecting to Close First of Many Contemplated M&A TransactionsColumbus, Ohio--(Newsfile Corp. - May 2, 2022) - Better For…